SCHEMBL2117024

SCHEMBL2117024

CC(C)Cc1ccc2ccccc2c1S

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
CYP2A6 P11509 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38
KDM4E B2RXH2 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
HPRT1 P00492 1/20 0.37
CYP1A2 P05177 2/20 0.35
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL271166 0.79 TDP1 (0.45) ALDH1A1TDP1CYP2A6TSHRHSD17B10
SCHEMBL6547337 0.79 TSHR (0.50) ALDH1A1TDP1CYP2A6TSHRHSD17B10
SCHEMBL1402335 0.79 CYP2A6 (0.44) ALDH1A1TDP1CYP2A6TSHRHSD17B10
SCHEMBL1244380 0.78 ALDH1A1 (0.39) ALDH1A1TDP1CYP2A6TSHRHSD17B10
Hydrogen Sulfide SCHEMBL28084470 0.78 TDP1 (0.44) ALDH1A1TDP1CYP2A6TSHRHSD17B10
SCHEMBL11036721 0.78 GABRA1 (0.57) GABRA1GABRB2
SCHEMBL248762 0.78 TDP1 (0.44) ALDH1A1TDP1CYP2A6TSHRHSD17B10
SCHEMBL248763 0.78 TDP1 (0.44) ALDH1A1TDP1CYP2A6TSHRHSD17B10
SCHEMBL2117021 0.76 USP2 (0.39) ALDH1A1TDP1CYP2A6TSHRHSD17B10
SCHEMBL11207425 0.76 TDP1 (0.43) ALDH1A1TDP1CYP2A6TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDTJYLLAND (DK) 2013-05-16 US claimed
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDT JYLLAND (DK) 2012-04-19 US claimed
EP-2398760-A1 ALLOSTERIC BINDING COMPOUNDS Aarhus Universitet (DK) 2011-12-28 EP claimed
WO-2010094289-A1 ALLOSTERIC BINDING COMPOUNDS AARHUS UNIVERSITET (DK) 2010-08-26 WO claimed
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDTJYLLAND (DK) 2013-05-16 US disclosed
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDT JYLLAND (DK) 2012-04-19 US disclosed
EP-2398760-A1 ALLOSTERIC BINDING COMPOUNDS Aarhus Universitet (DK) 2011-12-28 EP disclosed
WO-2010094289-A1 ALLOSTERIC BINDING COMPOUNDS AARHUS UNIVERSITET (DK) 2010-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS GRIN2C, GRM2, GRIN2B ALDH1A1 3676/4885TDP1 2112/4885CYP2A6 990/4885
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS GRIN2C, GRM2, GRIN2B ALDH1A1 3676/4885TDP1 2112/4885CYP2A6 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.